EFL

Cohort Year: 2021-2022

Tracks: Life Sciences

VISIT WEBSITE

Entelexo Biotherapeutics

Entelexo is developing next-generation exosome-based therapeutics to address incurable autoimmune diseases by specifically targeting autoreactive immune cells for effective treatment with mitigated side effects.